Ramipril tablet, Ramipril tablet India, Ramipril tablet manufacturers India
ثبت نشده
چکیده
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this Report is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider. Active P h a r m a c e u t i c a l I n g r e d i e n t s m a n u f a c t u r e r , e x p o r t e r , d r u g i n g r e d i e n t s , p h a r m a c e u t i c a l s , I n d i a Additionally, contact information on this Report cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to Ramipril tablet, Ramipril tablet India, Ramipril tablet manufacturers India, side effects Ramipril tablet manufacturers, Taj Pharma India, Ramipril tablet overdose, Ramipril tablet drug, Ramipril tablet composition, Manufacturing Pharmaceutical, Ramipril tablet brand, contains, Ramipril tablet India, Ramipril tablet side effects, Ramipril tablet
منابع مشابه
Altace Tablets (ramipril) USE IN PREGNANCY When used in pregnancy during the second and third trimesters, ACE inhibitors
Altace Tablets (ramipril) are supplied as tablets for oral administration containing 1.25 mg, 2.5 mg, 5 mg and 10 mg of ramipril. The inactive ingredients present are calcium sulphate dihydrate, pregelatinized starch, sodium bicarbonate, and sodium stearyl fumarate. The 2.5 mg tablet contains yellow iron oxide and FD&C yellow #6, the 5 mg tablet contains FD&C yellow #6 and FD&C red #40, and the...
متن کاملALTACE Tablets (ramipril) WARNING: FETAL TOXICITY
ALTACE Tablets (ramipril) are supplied as tablets for oral administration containing 1.25 mg, 2.5 mg, 5 mg and 10 mg of ramipril. The inactive ingredients present are calcium sulphate dihydrate, pregelatinized starch, sodium bicarbonate, and sodium stearyl fumarate. The 2.5 mg tablet contains yellow iron oxide and FD&C yellow #6, the 5 mg tablet contains FD&C yellow #6 and FD&C red #40, and the...
متن کاملSimultaneous RP-HPLC estimation and validation of ramipril and atorvastatin in bulk and combined tablet formulation
A simple, precise, accurate and reproducible RP-HPLC method was developed and validated for simultaneous estimation of ramipril and atorvastatin in bulk and combined pharmaceutical formulations. Separation of ramipril and atorvastatin was successfully achieved on an Inertsil ODS C18 column (150mm x 4.6mm x 5 μm). The mobile phase consisted of 0.1% ortho phosphoric acid and methanol (60:40, v/v)...
متن کاملRp- Hplc Method for Simultaneous Estimation of Metolazone and Ramipril in Oral Solid Dosage Form
A Simple, efficient and reproducible reverse phase high performance liquid chromatographic method was developed and validated for the Simultaneous determination of metolazone (MET) and ramipril (RAM) in combined dosage form. The separation was effected on a Hypersil ODS C18 column (250 mm x 4.6 mm;5μ) using a mobile phase mixture of 30mM sodium dihydrogen phosphate buffer adjusted to pH 2.5.0 w...
متن کاملComparative Bioavailability Study of Two Ramipril Tablet Formulations in Indonesian Healthy Volunteers
A single-dosed, open-label, randomized two-way crossover design under fasting period with two weeks wash out period was evaluated in 24 subjects. For the analysis of pharmacokinetic properties, the blood samples were drawn taken up to 72 hours after dosing. Plasma concentration of ramipril and ramiprilat were determined using liquid chromatography – tandem mass spectrometry method with TurboIon...
متن کامل